3 results  1 of 1 

1 Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia
Grisuna Singh, Sejin Song, Eunjoo Choi, Pyung-Bok Lee, Francis Sahngun Nahm
Korean J Pain.2020;33(3):201-207.   Published online 2020 July 1     DOI: http://dx.doi.org/10.3344/kjp.2020.33.3.201
      
2 Evaluation of Protective Immunity of Peptide Vaccines Composed of a 15-mer N-terminal Matrix Protein 2 and a Helper T-Cell Epitope Derived from Influenza A Virus
Jeong-Ki Kim, Sinyoung Cheong, Myung Kyu Lee
Immune Netw.2019;19(4):e29.  Published online 2019 July 23     DOI: http://dx.doi.org/10.4110/in.2019.19.e29
      
3 Development of Actinobacillus pleuropneumoniae ApxI, ApxII, and ApxIII-specific ELISA methods for evaluation of vaccine efficiency
Myunghwan Jung, Hokeun Won, Min-Kyoung Shin, Myung Whan Oh, Soojin Shim, Injoong Yoon, Han Sang Yoo
J Vet Sci.2019;20(2):e2.  Published online 2019 February 19     DOI: http://dx.doi.org/10.4142/jvs.2019.20.e2
      

 1 of 1